NCT07518524

Brief Summary

Fast-track cardiac anesthesia (FTCA) has gained significant popularity over the past decades due to its potential to reduce healthcare costs and optimize the use of medical resources. This approach has led anesthesiologists to reconsider the traditional model of cardiac anesthesia, known as Conventional Cardiac Anesthesia (CCA), which historically relied on the administration of high-dose opioids to ensure adequate hemodynamic stability and prolonged postoperative analgesia, thereby reducing the incidence of myocardial ischemia. One of the primary goals of fast-track cardiac anesthesia is early tracheal extubation. Increasing evidence demonstrates that early extubation is associated with a reduction in the length of stay in the intensive care unit (ICU) and overall hospital length of stay, resulting in significant cost savings without negatively affecting patients' clinical outcomes. In contrast, prolonged mechanical ventilation has been shown to have a substantial economic impact and, more importantly, is associated with higher in-hospital mortality and reduced long-term survival, including decreased five-year survival rates. The Ultra Fast Track protocol, which involves extubation directly in the operating room, is currently less commonly used. However, it may further reduce postoperative mechanical ventilation time and the incidence of pulmonary complications, potentially leading to an additional reduction in hospital length of stay. The aim of this study is to compare the Fast Track and Ultra Fast Track protocols in order to evaluate differences in the incidence of respiratory, cardiac, renal, septic, and neurological complications. Postoperative pain will also be assessed using the Numeric Rating Scale (NRS), as well as the incidence of postoperative nausea and vomiting (PONV).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
18mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Jun 2025Dec 2027

Study Start

First participant enrolled

June 18, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

March 10, 2026

Completed
29 days until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2027

Expected
Last Updated

April 8, 2026

Status Verified

March 1, 2026

Enrollment Period

9 months

First QC Date

March 10, 2026

Last Update Submit

April 7, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative pulmonary complications

    Incidence of postoperative pulmonary complications (PPCs), defined as a composite outcome including pneumonia, pleural effusion, atelectasis, or pneumothorax, within 7 days after ICU discharge or before hospital discharge (whichever occurs first), according to European Perioperative Clinical Outcome (EPCO) definitions. Unit of Measure: Percentage of participants with at least one PPC.

    From ICU discharge to Day 7 post-discharge

Secondary Outcomes (6)

  • Efficacy and safety on postoperative recovery

    From ICU discharge to Day 7 post-discharge

  • Efficacy and safety on postoperative recovery

    From ICU discharge to Day 7 post-discharge

  • Efficacy and safety on postoperative recovery

    From ICU discharge to Day 7 post-discharge

  • Efficacy and safety on postoperative recovery

    From ICU discharge to Day 7 post-discharge

  • Efficacy and safety on postoperative recovery

    From date of surgery until hospital discharge, up to 30 days

  • +1 more secondary outcomes

Study Arms (2)

Fast track cardiac anesthesia (FTCA)

ACTIVE COMPARATOR

Participants undergoing cardiac surgery via minithoracotomy receive a Fast Track Cardiac Anesthesia (FTCA) protocol.

Procedure: Fast Track Cardiac Anesthesia (FTCA)

Ultra Fast Track cardiac anesthesia (UFTCA)

ACTIVE COMPARATOR

Participants undergoing cardiac surgery via minithoracotomy receive an Ultra Fast Track Cardiac Anesthesia (UFTCA) protocol, with the goal of tracheal extubation in the operating room immediately after completion of surgery, followed by postoperative monitoring and care according to standard institutional practice.

Procedure: Ultra Fast Track Cardiac Anesthesia (UFTCA)

Interventions

Tracheal extubation in the operating room immediately after completion of surgery, followed by postoperative monitoring and care according to standard institutional practice.

Ultra Fast Track cardiac anesthesia (UFTCA)

Balanced general anesthesia with early extubation within 6 hours after surgery, followed by standard postoperative monitoring and care in the intensive care unit according to institutional practice.

Fast track cardiac anesthesia (FTCA)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients over 18 years of age
  • All patients scheduled for elective off-pump cardiac surgery or minimally invasive valve surgery via minithoracotomy, who provide explicit consent to participate in the protocol and sign the informed consent form.

You may not qualify if:

  • Patients extubated more than 6 hours postoperatively
  • Positive pregnancy test
  • Patients who, for clinical reasons, cannot be awakened in the operating room, including difficult intubation, respiratory failure with P/F ratio \< 200, hemodynamic instability requiring more than one vasoactive drug, cardiopulmonary bypass duration \> 150 minutes, active perioperative bleeding, core temperature \< 35°C.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Trial Office

Legnano, Italy, 20025, Italy

RECRUITING

Central Study Contacts

Trial office Trial Office

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 10, 2026

First Posted

April 8, 2026

Study Start

June 18, 2025

Primary Completion

March 1, 2026

Study Completion (Estimated)

December 15, 2027

Last Updated

April 8, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations